Global Cardiac Implants Market
Cardiovascular disease kills 17.3 million people a year while HIV/Aids, malaria and tuberculosis altogether kill 3.86 million. Heart diseases cases reported in hospital are almost 3.7 million every year and they stay in hospital for 4.6 days on an average. There are around 12.4 million visits to the respective physician every year made by heart disease related patients.
Goldstein Research analyst forecast the Cardiac Implants Market size is set to reach USD 56.59 billion by 2024, at a CAGR of 10.0% over the forecast years.
Covered In This Global Cardiac Implants Market Report
The report covers the present ground scenario and the future growth prospects of the Cardiac Implants Market for 2016-2024 along with the statistics of cardiovascular disease penetration worldwide. We calculated the market size and revenue share on the basis of revenue generated and sales of various categories of Cardiac Implants from major players across the globe.
Global Cardiac Implants Market Segmentation
On The Basis of Type
Cardiac Rhythm Management Devices
Heart Valves (Artificial & Replacement)
Ventricular Assist Devices
Others (Neurostimulator, etc)
Acute Myocardial Infarction
Based on Geography
North America (U.S. & Canada) Cardiac Implants Market
Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Cardiac Implants Market
Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Cardiac Implants Market
Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Cardiac Implants Market
Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Cardiac Implants Market
On the basis of type, stents hold the largest market share i.e. 42% in the global cardiac implants market owing to the fact that heart diseases are the number one cause of death, around 15% of people that have heart attack die from it. Adoption of smoke habits, poor diet plans, lack of exercise and excessive alcoholism drives the cardiac disease market.
Cardiac Implants Market Outlook 2016-2024, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Cardiac Implants market. The report also includes porters five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.
Our global cardiac implants market report comprises of the following companies as the key players in the cardiac implants market: Abbott Laboratories, Medtronic, Roche, C. R. Bard, Inc, B. Braun Melsungen, Biotronik, Boston Scientific, Elixir Medical Corporation, W. L. Gore & Associates, Bentley InnoMed GmbH, Elestim-Cardio.
According to our global market study on the basis of extensive primary and secondary research: One trend is the evolution of cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) and advent of new concepts for cardiac technology that requires successful commercialization. Technologies like HVAD pump, HeartMate 3, Cardialen, Watchman, Parachute Implant have potential to disrupt the market as new standards for patient care.
According to the report, major driving factor for Cardiac Implants market is increasing aging population and focusing on fitness & healthy lifestyle is predicted to raise the cardiac implants market globally. In Japan, 25.8% of the total population was above the age of 65 and according to the World Bank Data, the growth in aging population is projected around 32.2% of the total population by 2030.
Further, the report states that the major challenge is the issues with biocompatibility and the propensity of the implanted constructs to get infected over time remain. The highly invasive nature of many surgical procedures coupled with numerous serious health conditions and inadequate immune response frequently observed in the implant recipients make these individuals highly vulnerable to implant-associated infections.
Based on geography, North America dominates the Cardiac Implants market with almost 47% market share in 2016. Heart disease affects whites and African Americans the most, accounting for 24.3 and 24.1 percent of deaths, respectively. Asians and Pacific Islanders are at third-highest risk for a heart disease-related death, at 22.5 %. It accounts for 20.8 % of deaths in the Hispanic community, and 17.9 % in American Indians and Alaska Natives.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
For a full detailed overview, send us the sample request.
Key questions answered in this Cardiac Implants Market report
What is the total market size by 2024 and what would be the expected growth rate of the market?
What is the revenue of Cardiac Implants in 2015-16 and what would be the expected demand over the forecast period?
What are the key market trends?
What are the factors which are driving this market?
What are the major barriers to market growth?
Who are the key vendors in this market space?
What are the market opportunities for the existing and entry level players?
What are the recent developments and business strategy of the key players?
We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.